Menin-MLL inhibitor 20

目录号: PL13435 纯度: ≥97%
Menin-MLL inhibitor 20 是一种不可逆的 menin-MLL 相互作用的抑制剂,具有抗肿瘤活性 (WO2020142557A1, Intermediate 6)。
CAS No. :2448173-47-3
商品编号 规格 价格 会员价 是否有货 数量
PL13435-5mg 5mg ¥828.00 请登录
PL13435-10mg 10mg ¥1375.00 请登录
PL13435-25mg 25mg ¥2325.00 请登录
PL13435-50mg 50mg ¥3325.00 请登录
PL13435-100mg 100mg ¥4685.00 请登录
PL13435-200mg 200mg ¥6315.00 请登录
PL13435-500mg 500mg 询价 询价
PL13435-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3005.00 请登录
PL13435-1 mL x 10 mM (in DMSO) ¥925.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Menin-MLL inhibitor 20
英文名称
Menin-MLL inhibitor 20
英文别名
tert-butyl N-[(3R)-1-[[2-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]carbamoyl]pyri;Menin-MLL inhibitor 20
Cas No.
2448173-47-3
分子式
C33H40N8O4
分子量
612.72
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Menin-MLL inhibitor 20 是一种不可逆的 menin-MLL 相互作用的抑制剂,具有抗肿瘤活性 (WO2020142557A1, Intermediate 6)。
产品详情
Menin-MLL inhibitor 20 是一种不可逆的 menin-MLL 相互作用的抑制剂,具有抗肿瘤活性 (WO2020142557A1, Intermediate 6)。
生物活性
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, Intermediate 6).
性状
Solid
体外研究(In Vitro)
The Histone-lysine N-methyltransferase 2 (KMT2) family of proteins, which currently consists of at least 5 members, methylate ly sine 4 on the histone H3 tails at important regulatory regions in the genome and thereby impart crucial functions through the modulation of chromatin structures and DNA accessibility. These enzymes are known to play an important role in the regulation of gene expression during early development and hematopoiesis. The human KMT2 family was initially named the mixed-lineage leukaemia (MLL) family, owing to the role of the first-found member in this disease. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Thomas Butler, et al. Irreversible inhibitors of menin-mll interaction. WO2020142557A1.
溶解度数据
In Vitro: DMSO : 33.33 mg/mL (54.40 mM; ultrasonic and warming and heat to 60°C)配制储备液
搜索质检报告(COA)
[1]. Thomas Butler, et al. Irreversible inhibitors of menin-mll interaction. WO2020142557A1.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2